3189 results for «686»

Filter By

3189 results

Mastering complex CTO interventions: Techniques, challenges, and innovations

04 Oct 2024 – From AICT-AsiaPCR 2024

Immerse yourself in a comprehensive CTO session featuring a selection of complex and challenging cases from the AICT-AsiaPCR 2024 conference. Discover innovative techniques and strategies for navigating highly calcified and tortuous CTO lesions, utilizing IVUS guidance, managing coronary perforations, and optimizing CTO PCI planning with left...

Mastering complex CTO interventions: Techniques, challenges, and innovations

Breakthrough studies: Key abstracts on PCI, TAVI and mitral valve repair

04 Oct 2024 – From AICT-AsiaPCR 2024

Discover the cutting-edge research and innovative solutions presented in the 'Best Abstracts of AICT-AsiaPCR 2024' session. This curated selection showcases the latest advancements in interventional cardiology, from groundbreaking comparisons of transcatheter mitral valve repair techniques to the impact of cerebral embolic protection devices in TAVI procedures....

Breakthrough studies: Key abstracts on PCI, TAVI and mitral valve repair

Managing severe calcified LAD lesions in STEMI: Insights from three cases

04 Oct 2024 – From AICT-AsiaPCR 2024

Dive into this compelling presentation highlighting three challenging STEMI cases involving severe proximal LAD calcified stenosis. Witness the ingenuity of interventional strategies as the presenter explores how drug-coated balloons can be a viable alternative to stents in acute MI management. Don't miss this opportunity to deepen...

Managing severe calcified LAD lesions in STEMI: Insights from three cases

Advanced TAVI techniques for complex anatomies and high-risk patients

04 Oct 2024 – From AICT-AsiaPCR 2024

Explore a collection of captivating clinical cases from AICT-AsiaPCR 2024, delving into the intricacies of Transcatheter Aortic Valve Implantation (TAVI). Witness the ingenuity and expertise of interventional cardiologists as they navigate complex anatomies, challenging access routes, and unique patient presentations. From managing bicuspid aortic stenosis to...

Advanced TAVI techniques for complex anatomies and high-risk patients

The turning point in hypertension care: renal denervation in practice

04 Oct 2024 – From AICT-AsiaPCR 2024

Explore the latest advancements in hypertension care with this session on renal denervation. Stay up-to-date with the latest guidelines for hypertension treatment using renal denervation. Delve into the importance of patient selection and their preferences, and understand the key steps to perform a safe and effective...

The turning point in hypertension care: renal denervation in practice

Resorbable magnesium scaffolds - Unveiling the future

04 Oct 2024 – From AICT-AsiaPCR 2024

Explore the future of coronary interventions with this session on resorbable magnesium scaffolds (RMS). Understand the limitations of drug-eluting stents and the emerging role of resorbable scaffolds. Delve into the technology behind RMS, including the key features and degradation characteristics of the new generation Freesolve RMS....

Resorbable magnesium scaffolds - Unveiling the future

A randomised trial comparing imaging-guided PCI with Orsiro vs Xience

18 May 2021

Previous clinical trials suggested that ultra-thin strut biodegradable polymer sirolimus-eluting stent (BP-SES) may be associated with lower target lesion failure (TLF) when compared to durable polymer everolimus-eluting stents (DP-EES). However, the possible underlying mechanisms remain unclear. Therefore, the all-comers CASTLE study was designed to assess the...

Authors :

A randomised trial comparing imaging-guided PCI with Orsiro vs Xience

RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

05 Sep 2023

Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.

Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...

Alessandro Sticchi

Author

Alessandro Sticchi
RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

BIOFLOW DAPT - Biodegradable-polymer or durable-polymer stents in patients at high bleeding risk: A randomized, open-label clinical trial

26 Aug 2023

Nicola Ryan reports on the BIOFLOW DAPT trial results presented during the ESC 2023 Congress in Amsterdam by Marco Valgimigli and published in Circulation.

BIOFLOW-DAPT is an open-label randomised trial comparing the safety and efficacy of a biodegradable-polymer sirolimus-eluting stent with a durable-polymer zotarolimus-eluting stent in high-bleeding risk patients...

Nicola Ryan

Author

Nicola Ryan
BIOFLOW DAPT - Biodegradable polymer SES vs durable polymer ZES in HBR subjects with 1-month DAPT
Didn’t find what you were looking for?